Hospital
Clayton Health Systems INC
Clayton Health Systems INC was paid $1.80M by Medicaid between Jan 2018 and Dec 2024, across 52 billing codes. Its largest line is 99283, emergency room visit (moderate) — 35% of everything it billed.
33Billing provider infoCLAYTON HEALTH SYSTEMS INC
CLAYTON, NM 88415
CLAYTON, NM 88415
33aNPI1427051002assigned 05/27/2005
33bProvider typeCritical Access Hospital
28Total paid$1.80M
24GClaims24,270
24DCodes billed52
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in New Mexico
Rank by total paid#6 of 6
Median peer was paid$15.48M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,049 | $243K | |
| 2019 | 3,015 | $223K | |
| 2020 | 2,242 | $146K | |
| 2021 | 2,969 | $255K | |
| 2022 | 4,145 | $242K | |
| 2023 | 4,121 | $328K | |
| 2024incomplete | 3,729 | $365K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 35% | 2,974 | 2,357 | $636K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 937 | 741 | $295K |
| 80053 | Comprehensive metabolic panel | 9.3% | 3,723 | 3,330 | $167K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.1% | 692 | 601 | $109K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 6.0% | 377 | 368 | $109K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.3% | 122 | 106 | $78K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.1% | 1,017 | 231 | $73K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.1% | 3,627 | 3,257 | $73K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.2% | 242 | 191 | $39K |
| 36415 | Collection of venous blood by venipuncture | 2.2% | 5,025 | 4,267 | $39K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 151 | 124 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 335 | 268 | $16K |
40 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 139 | $15K |
| 86140 | <1% | 741 | $12K | |
| 85652 | <1% | 592 | $9K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 82 | $9K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 89 | $8K |
| 81002 | <1% | 1,069 | $7K | |
| 86738 | <1% | 128 | $6K | |
| 0001A | <1% | 88 | $6K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 34 | $6K |
| 86710 | <1% | 200 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 266 | $6K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 318 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 31 | $4K |
| 71045 | Radiologic examination, chest; single view | <1% | 47 | $4K |
| 91300 | <1% | 142 | $4K | |
| 0002A | <1% | 76 | $4K | |
| 80061 | Lipid panel | <1% | 135 | $3K |
| 0003A | <1% | 24 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 35 | $3K |
| 86677 | <1% | 77 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 53 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 30 | $2K |
| 87430 | <1% | 37 | $1K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 65 | $1K |
| 97162 | <1% | 15 | $1K | |
| A9570 | Indium in-111 labeled autologous white blood cells, diagnostic, per study dose | <1% | 117 | $1K |
| 82805 | <1% | 16 | $875.36 | |
| 81000 | <1% | 107 | $831.34 | |
| 94760 | <1% | 30 | $729.07 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 42 | $726.56 |
| 87070 | <1% | 45 | $718.34 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 32 | $685.95 |
| 87077 | <1% | 30 | $471.98 | |
| 87186 | <1% | 14 | $264.16 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 18 | $251.63 |
| 83721 | <1% | 12 | $197.99 | |
| 85032 | <1% | 12 | $178.67 | |
| 85610 | <1% | 23 | $172.42 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 19 | $162.97 |
| 83735 | <1% | 18 | $143.37 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHAVEZ, TAMMIE (CEO)
| Provider | Location | Paid |
|---|---|---|
| Clayton Health Systems, INC | Clayton, NM | $669K |
| Clayton Health Systems INC | Clayton, NM | $80K |
| Clayton Health Systems INC | Clayton, NM | $443.35 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.